Allianz Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-682,523
| Closed | -$121M | – | 2635 |
|
|
2020
Q1 | $121M | Sell |
682,523
-72,595
| -10% | -$13.7M | 0.16% | 147 |
|
|
2019
Q4 | $144M | Sell |
755,118
-69,224
| -8% | -$12.5M | 0.13% | 169 |
|
|
2019
Q3 | $139M | Sell |
824,342
-21,684
| -3% | -$3.53M | 0.14% | 162 |
|
|
2019
Q2 | $142M | Sell |
846,026
-36,480
| -4% | -$5.05M | 0.13% | 167 |
|
|
2019
Q1 | $129M | Sell |
882,506
-34,223
| -4% | -$4.96M | 0.13% | 171 |
|
|
2018
Q4 | $123M | Buy |
916,729
+79,077
| +9% | +$13M | 0.13% | 166 |
|
|
2018
Q3 | $160M | Sell |
837,652
-16,795
| -2% | -$3.09M | 0.14% | 162 |
|
|
2018
Q2 | $142M | Sell |
854,447
-147,453
| -15% | -$23.7M | 0.14% | 159 |
|
|
2018
Q1 | $169M | Buy |
1,001,900
+131,031
| +15% | +$22M | 0.16% | 136 |
|
|
2017
Q4 | $142M | Buy |
870,869
+189,329
| +28% | +$34M | 0.11% | 212 |
|
|
2017
Q3 | $140M | Buy |
681,540
+186,265
| +38% | +$43.3M | 0.12% | 193 |
|
|
2017
Q2 | $121M | Buy |
495,275
+104,896
| +27% | +$24.6M | 0.12% | 198 |
|
|
2017
Q1 | $93.3M | Sell |
390,379
-576,871
| -60% | -$134M | 0.09% | 252 |
|
|
2016
Q4 | $203M | Buy |
967,250
+168,476
| +21% | +$34.9M | 0.18% | 115 |
|
|
2016
Q3 | $184M | Buy |
798,774
+76,222
| +11% | +$18.6M | 0.18% | 120 |
|
|
2016
Q2 | $167M | Buy |
722,552
+221,334
| +44% | +$51M | 0.18% | 122 |
|
|
2016
Q1 | $134M | Buy |
501,218
+115
| +0% | +$32.9K | 0.15% | 138 |
|
|
2015
Q4 | $157M | Sell |
501,103
-383,073
| -43% | -$114M | 0.18% | 114 |
|
|
2015
Q3 | $240M | Sell |
884,176
-149,498
| -14% | -$45.9M | 0.29% | 69 |
|
|
2015
Q2 | $314M | Sell |
1,033,674
-55,586
| -5% | -$16.6M | 0.33% | 62 |
|
|
2015
Q1 | $324M | Buy |
1,089,260
+269,534
| +33% | +$76.8M | 0.37% | 65 |
|
|
2014
Q4 | $211M | Buy |
819,726
+156,007
| +24% | +$39M | 0.23% | 88 |
|
|
2014
Q3 | $160M | Buy |
663,719
+65,892
| +11% | +$14.7M | 0.19% | 114 |
|
|
2014
Q2 | $133M | Buy |
597,827
+312,145
| +109% | +$64.6M | 0.17% | 137 |
|
|
2014
Q1 | $58.8M | Buy |
285,682
+231,264
| +425% | +$45.8M | 0.07% | 314 |
|
|
2013
Q4 | $9.14M | Buy |
54,418
+52,767
| +3,196% | +$8.25M | 0.01% | 763 |
|
|
2013
Q3 | $238K | Sell |
1,651
-94,021
| -98% | -$12.5M | ﹤0.01% | 1640 |
|
|
2013
Q2 | $12.1M | Buy |
+95,672
| New | +$10.8M | 0.02% | 594 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Allianz Asset Management's AGN Position: Q2 2020 in Review
Allianz Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 682,523 shares — an estimated $121M sold.
Allianz Asset Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $324M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Allianz Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Allianz Asset Management sold 682,523 Allergan plc shares in Q2 2020, an estimated $121M.
- Allianz Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Allianz Asset Management's Allergan plc position peaked at $324M in Q1 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.